Nevada Type 2 Diabetes Report

This is the 12th edition of the Nevada Type 2 Diabetes ReportTM for 2019, an overview of key demographic, utilization, charge, and pharmacotherapy measures for Type 2 diabetes patients in key local markets in Nevada. The report also provides comparisons to Los Angeles, Salt Lake City, state of Nevada, and national benchmarks, which can help providers and employers identify opportunities to better serve the needs of their patients. All data are drawn from the Sanofi Managed Care Digest Series®. This report also includes measures on cardiovascular diseases and other conditions that often occur as complications and comorbidities of Type 2 diabetes. The data provided explore the impact of these conditions on the patient’s treatment—including lab results, therapy persistency, and charges generated in their care—and by doing so reinforce the importance of earlier prevention and treatment for Nevada patients with Type 2 diabetes to delay or avoid these conditions.